PARTNERING & INVESTING

The NFP-E™ System is the first automated tool for precise electroporation of individual cells at a scale that enables new capabilities for fundamental research and cellular engineering. Our goal is to develop the technology’s broad potential in the market segments shown below.

Infinitesimal is interested in establishing collaborations, partnerships, and investments across these markets and applications. For more information, please contact infinitesimal@infinitesimal-llc.com

Academia

• Single cell research
• Gene editing
• Synthetic biology
• Stem cell research

Biotech/Pharma

• Custom cell line generation
• Gene editing
• Drug response testing
• Toxicity testing

Healthcare

• Production of cell therapies
• Rare cell diagnostics
• Personalized drug testing
• Personalized drug dosing